Viewing Study NCT03481660

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:11 AM
Ignite Modification Date: 2026-04-12 @ 1:37 PM
Study NCT ID: NCT03481660
Status: COMPLETED
Last Update Posted: 2025-01-07
First Post: 2018-03-19
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study of the Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetic Macular Edema View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Diabetic Macular Edema View
None intravitreal injection View
None brolucizumab View
None aflibercept View
None double-masked View